A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma

Gastroenterology

Volumn 141, Issue 1, 2011, Pages 141-149

  Abu Dayyeh, Barham K ^a,b   Yang, May ^c   Fuchs, Bryan C ^a,b   Karl, Daniel L ^a,b   Yamada, Suguru ^a,b   Sninsky, John J ^d   O'Brien, Thomas R ^e   Dienstag, Jules L ^a,b   Tanabe, Kenneth K ^a,b   Chung, Raymond T ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d CELERA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; HCV; Liver Disease; Prognosis; Tumor

Indexed keywords

ALKALINE PHOSPHATASE; EPIDERMAL GROWTH FACTOR; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLELE; ANTIVIRAL THERAPY; ARTICLE; CANCER RISK; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT;

EID: 79959996152     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.03.045     Document Type: Article

References (40)

1. D.M. Parkin The global health burden of infection-associated cancers in the year 2002 Int J Cancer 118 2006 3030 3044
2. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
3. R.F. Velazquez, M. Rodriguez, and C.A. Navascues Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 2003 520 527 (Pubitemid 36258772)
4. H. Tsukuma, T. Hiyama, and S. Tanaka Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797 1801 (Pubitemid 23174709)
5. H.B. El-Serag, J.A. Marrero, and L. Rudolph Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 2008 1752 1763 (Pubitemid 351615415)
6. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236 (Pubitemid 43112690)
7. F. Trevisani, P.E. D'Intino, and A.M. Morselli-Labate Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J Hepatol 34 2001 570 575 (Pubitemid 32328514)
8. N. Bayati, A.L. Silverman, and S.C. Gordon Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C Am J Gastroenterol 93 1998 2452 2456 (Pubitemid 29018554)
9. C.K. Kim, J.H. Lim, and W.J. Lee Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients J Ultrasound Med 20 2001 99 104
10. L. Bolondi, S. Sofia, and S. Siringo Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Gut 48 2001 251 259 (Pubitemid 32141852)
11. R.R. Tonjes, J. Lohler, and J.F. O'Sullivan Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice Oncogene 10 1995 765 768
12. S.E. Singletary, F.L. Baker, and G. Spitzer Biological effect of epidermal growth factor on the in vitro growth of human tumors Cancer Res 47 1987 403 406 (Pubitemid 17009599)
13. P. Blanc, H. Etienne, and M. Daujat Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum Gastroenterology 102 1992 1340 1350
14. G. Giannelli, C. Sgarra, and L. Porcelli EGFR and VEGFR as potential target for biological therapies in HCC cells Cancer Lett 262 2008 257 264
15. K. Okamoto, D. Neureiter, and B. Alinger The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice Int J Oncol 33 2008 733 742
16. E. Schiffer, C. Housset, and W. Cacheux Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis Hepatology 41 2005 307 314 (Pubitemid 40165374)
17. M. Shahbazi, V. Pravica, and N. Nasreen Association between functional polymorphism in EGF gene and malignant melanoma Lancet 359 2002 397 401 (Pubitemid 34158948)
18. L.O. Almeida, A.C. Custodio, and M.J. Santos The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival Cancer Genet Cytogenet 198 2010 15 21
19. M. Lanuti, G. Liu, and J.M. Goodwin A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome Clin Cancer Res 14 2008 3216 3222
20. K.K. Tanabe, A. Lemoine, and D.M. Finkelstein Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis JAMA 299 2008 53 60
21. A.S. Lok, L.B. Seeff, and T.R. Morgan Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease Gastroenterology 136 2009 138 148
22. A.M. Di Bisceglie, M.L. Shiffman, and G.T. Everson Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon N Engl J Med 359 2008 2429 2441
23. J.E. Everhart, E.C. Wright, and Z.D. Goodman Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial Hepatology 51 2010 585 594
24. K. Ishak, A. Baptista, and L. Bianchi Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
25. S. Germer, and R. Higuchi Homogeneous allele-specific PCR in SNP genotyping Methods Mol Biol 212 2003 197 214
26. A. Grupe, Y. Li, and C. Rowland A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease Am J Hum Genet 78 2006 78 88 (Pubitemid 41833161)
27. Y. Oka, and D.N. Orth Human plasma epidermal growth factor/beta- urogastrone is associated with blood platelets J Clin Invest 72 1983 249 259 (Pubitemid 13025866)
28. J.M. Llovet, and J. Bruix Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 2008 1312 1327
29. Y. Morimitsu, C.C. Hsia, and M. Kojiro Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor Hum Pathol 26 1995 1126 1132
30. L.G. Komuves, A. Feren, and A.L. Jones Expression of epidermal growth factor and its receptor in cirrhotic liver disease J Histochem Cytochem 48 2000 821 830 (Pubitemid 30366616)
31. W. Xu, Y. Li, and X. Wang Association between EGF promoter polymorphisms and cancer risk: a meta-analysis Med Oncol 27 2010 1389 1397
32. P.M. Price, J. Megyesi, and S. Saggi Regulation of transcription by the rat EGF gene promoter in normal and ischemic murine kidney cells Am J Physiol 268 1995 F664 F670
33. Y. Li, Q. Xie, and F. Lu Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients Liver Int 30 2010 112 118
34. S. Noguchi, Y. Ohba, and T. Oka Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice J Endocrinol 128 1991 425 431
35. D.E. Jones Jr, R. Tran-Patterson, and D.M. Cui Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration Am J Physiol 268 1995 G872 G878
36. A. Natarajan, B. Wagner, and M. Sibilia The EGF receptor is required for efficient liver regeneration Proc Natl Acad Sci U S A 104 2007 17081 17086 (Pubitemid 350210995)
37. K.D. Bissig, U. Marti, and M. Solioz Epidermal growth factor is decreased in liver of rats with biliary cirrhosis but does not act as paracrine growth factor immediately after hepatectomy J Hepatol 33 2000 275 281 (Pubitemid 30485231)
38. S. Kuriyama, F. Yokoyama, and H. Inoue Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model Int J Mol Med 19 2007 317 324
39. Y. Hoshida, A. Villanueva, and M. Kobayashi Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
40. J. Furuse Growth factors as therapeutic targets in HCC Crit Rev Oncol Hematol 67 2008 8 15